Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News VolitionRX Ltd VNRX

Healthcare Medical Instruments & Supplies
VolitionRx Limited is a multi-national epigenetics company focused on advancing the science of epigenetics. The Company is dedicated to saving lives and improving outcomes for people and animals with life-altering diseases through earlier detection, as well as disease and treatment monitoring. Through its subsidiaries, it is developing and commercializing blood tests to help diagnose and... see more

Recent & Breaking News (NYSEAM:VNRX)

VolitionRx Limited to Attend the Bank of America Merrill Lynch 2018 Health Care Conference from May 15-17, 2018

PR Newswire May 14, 2018

VolitionRx Limited Announces First Quarter 2018 Financial Results and Business Update

PR Newswire May 10, 2018

VolitionRx Signs a Global Sales and Distribution Agreement with Active Motif for its new RUO kits

PR Newswire May 9, 2018

VolitionRx Limited Schedules First Quarter 2018 Earnings Conference Call and Business Update

PR Newswire May 4, 2018

VolitionRx Announces Pricing of $8.4 Million Public Offering of Common Stock

PR Newswire March 9, 2018

VolitionRx Announces Proposed Underwritten Public Offering of Common Stock

PR Newswire March 8, 2018

VolitionRx Appoints Harvard Professor, Dr. Lee-Jen Wei to Its Scientific Advisory Board

PR Newswire March 7, 2018

VolitionRX Limited Announces Full Fiscal Year 2017 Financial Results and Business Update

PR Newswire March 1, 2018

VolitionRx Limited Schedules Full Year 2017 Earnings Conference Call and Business Update

PR Newswire February 28, 2018

VolitionRx Limited Announces Interim Results from 680-Subject Clinical Trial in Colorectal Cancer

PR Newswire February 26, 2018

VolitionRX Announces the Successful Conclusion of the Logistics and Pathway Design Study Conducted in Denmark.

PR Newswire February 5, 2018

VolitionRx Limited Releases Letter to Shareholders Including Status Update on Key Clinical Milestone

PR Newswire January 3, 2018

VolitionRx Limited to Attend Conferences in December

PR Newswire December 5, 2017

Singapore Volition signs Memorandum of Understanding with the National Taiwan University to Conduct Two Large Clinical Studies

PR Newswire November 10, 2017

Volitionrx Limited to Host Earnings Call

Accesswire November 10, 2017

VolitionRx Limited Announces Third Quarter 2017 Financial Results and Business Update

PR Newswire November 9, 2017

VolitionRx Limited Schedules Third Quarter 2017 Earnings Conference Call and Business Update

PR Newswire November 2, 2017

InvestmentPitch Media Invites Investors to the GCFF Conference in Toronto on September 30, 2017 - Video Hosted on InvestmentPitch.com

Newsfile September 28, 2017

VolitionRx Announces the Initial Sale of its New Nu.Q(TM) Research Kits

PR Newswire September 22, 2017

VolitionRx Limited Awarded $1.5 Million in Non-Dilutive Funding

PR Newswire September 21, 2017